Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Technologies - Radioactive and Nonradioactive Probes: Dosimetry & Image Analysis

Radiation dosimetry and biodistribution of BAY86-9596 (O-([18F]fluoromethyl)-D-tyrosine)

Johan de Jong, Kristin Kowal, Sabine Zitzmann-Kolbe, Claudia Bacher-Stier, Irene Burger, Erik de Vries and Jan Pruim
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 1455;
Johan de Jong
1Nuclear Medicine & Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kristin Kowal
2Bayer Schering Pharma AG, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sabine Zitzmann-Kolbe
2Bayer Schering Pharma AG, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claudia Bacher-Stier
2Bayer Schering Pharma AG, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Irene Burger
3Division of Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erik de Vries
1Nuclear Medicine & Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jan Pruim
1Nuclear Medicine & Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 52 no. supplement 1 1455

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online November 4, 2014.

Copyright & Usage 
© 2011

Author Information

  1. Johan de Jong1,
  2. Kristin Kowal2,
  3. Sabine Zitzmann-Kolbe2,
  4. Claudia Bacher-Stier2,
  5. Irene Burger3,
  6. Erik de Vries1 and
  7. Jan Pruim1
  1. 1Nuclear Medicine & Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, Netherlands
  2. 2Bayer Schering Pharma AG, Berlin, Germany
  3. 3Division of Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: November 2014 to April 2025

AbstractFullPdf
Nov 2014200
Dec 2014100
Feb 2015200
Jun 2015200
Jul 2015500
Sep 2015400
Oct 2015200
Feb 2016100
Jun 2016100
Jul 2016100
Aug 2016200
Sep 2016100
Oct 2016200
Nov 2016100
Dec 2016400
Jan 2017400
Feb 2017400
Apr 2017500
May 2017200
Jun 2017200
Jul 2017100
Oct 2017200
Jun 2018400
Sep 2018300
Nov 2018100
Dec 2018200
Jun 2019200
Sep 2019100
Oct 2019500
Feb 2020400
Mar 20201400
Apr 20201400
Jul 2020300
Aug 20201600
Sep 20203200
Oct 20201600
Nov 20202200
Dec 2020900
Jan 2021400
Feb 20211500
Mar 20211100
Apr 20211200
May 20211300
Jun 2021200
Jul 20211400
Aug 20213400
Sep 20211000
Oct 20211000
Nov 20216400
Dec 20214400
Jan 20226500
Feb 20222000
Mar 20222600
Apr 20221300
May 20222200
Jun 2022300
Aug 2022300
Sep 2022200
Oct 2022100
Nov 2022200
Dec 2022100
Jan 2023100
Feb 2023100
Mar 2023200
Apr 2023300
May 2023400
Jun 2023300
Jul 2023400
Aug 2023300
Sep 2023300
Oct 2023400
Nov 2023200
Dec 2023200
Jan 2024600
Feb 2024100
Mar 2024200
Apr 2024500
May 2024200
Jun 2024500
Jul 2024200
Aug 2024600
Sep 2024400
Oct 2024200
Nov 2024600
Dec 2024400
Jan 2025200
Feb 2025500
Mar 2025400
Apr 2025600
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 52, Issue supplement 1
May 2011
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Radiation dosimetry and biodistribution of BAY86-9596 (O-([18F]fluoromethyl)-D-tyrosine)
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Radiation dosimetry and biodistribution of BAY86-9596 (O-([18F]fluoromethyl)-D-tyrosine)
Johan de Jong, Kristin Kowal, Sabine Zitzmann-Kolbe, Claudia Bacher-Stier, Irene Burger, Erik de Vries, Jan Pruim
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 1455;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Radiation dosimetry and biodistribution of BAY86-9596 (O-([18F]fluoromethyl)-D-tyrosine)
Johan de Jong, Kristin Kowal, Sabine Zitzmann-Kolbe, Claudia Bacher-Stier, Irene Burger, Erik de Vries, Jan Pruim
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 1455;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Technologies - Radioactive and Nonradioactive Probes: Dosimetry & Image Analysis

  • BAY 94-9392: A novel F-18 labeled tumor specific probe for PET/CT imaging - Dosimetry
  • Whole-body distribution and radiation dosimetry of [11C]telmisartan as a biomarker for hepatic organic anion transporting polypeptide (OATP) 1B3
  • F-18 FDG PET imaging in pregnancy and fetal radiation dose estimates
Show more Molecular Targeting Technologies - Radioactive and Nonradioactive Probes: Dosimetry & Image Analysis

Dosimetry & Image Analysis Posters

  • BAY 94-9392: A novel F-18 labeled tumor specific probe for PET/CT imaging - Dosimetry
  • F-18 FDG PET imaging in pregnancy and fetal radiation dose estimates
  • Radiation exposure by (-)-F18-NCFHEB, a new PET tracer for imaging of cerebral alpha4beta2 nicotinic acetylcholine receptors (nAChRs)
Show more Dosimetry & Image Analysis Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire